Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 7-o-demethylsirolimus
2. 16-o-demethylrapamycin
3. Rapamycin, 7-o-demethyl-
4. Cj-12263
5. 7-o-demethyl Rapamycin
6. 2719uahua8
7. 7-o-demethyl Cypher
8. 7-o-demethylrapamycin
9. 16-o-demethylsirolimus
10. N-929-89b
11. 151519-50-5
12. 7-o-demethyl Rapammune
13. Novolimus (80%)
14. Unii-2719uahua8
15. Schembl7715643
16. Chembl3544688
17. 7-o-demethyl Rapamycin (~80%)
18. Cj12263
19. Cj 12263
20. Hy-123691
21. Cs-0084352
| Molecular Weight | 900.1 g/mol |
|---|---|
| Molecular Formula | C50H77NO13 |
| XLogP3 | 5.5 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 5 |
| Exact Mass | 899.53949151 g/mol |
| Monoisotopic Mass | 899.53949151 g/mol |
| Topological Polar Surface Area | 206 Ų |
| Heavy Atom Count | 64 |
| Formal Charge | 0 |
| Complexity | 1740 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 15 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 4 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Novolimus manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Novolimus, including repackagers and relabelers. The FDA regulates Novolimus manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Novolimus API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Novolimus supplier is an individual or a company that provides Novolimus active pharmaceutical ingredient (API) or Novolimus finished formulations upon request. The Novolimus suppliers may include Novolimus API manufacturers, exporters, distributors and traders.
Novolimus Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Novolimus GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Novolimus GMP manufacturer or Novolimus GMP API supplier for your needs.
A Novolimus CoA (Certificate of Analysis) is a formal document that attests to Novolimus's compliance with Novolimus specifications and serves as a tool for batch-level quality control.
Novolimus CoA mostly includes findings from lab analyses of a specific batch. For each Novolimus CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Novolimus may be tested according to a variety of international standards, such as European Pharmacopoeia (Novolimus EP), Novolimus JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Novolimus USP).
LOOKING FOR A SUPPLIER?
